XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Cash flows from operating activities:              
Net loss $ (2,887) $ (8,120) $ (7,200) $ (701) $ (11,227) $ (14,594)  
Adjustments to reconcile net loss to cash used in operating activities:              
Depreciation, amortization and accretion         6,328 6,699  
Stock-based compensation expense 811   902   2,561 5,146  
Loss (gain) on derivative warrant liabilities (1,017)   (2,573)   5,467 (6,167)  
Amortization of senior debt discount         463 413  
Inventory write-down 300   100   476 199  
Impairment expense 0   0   0 2,600  
Gain from contingent consideration 0   (734)   0 (504)  
Other noncash adjustments         (50) (29)  
Changes in operating assets and liabilities:              
Accounts receivable, net         (988) (12,335)  
Inventories         (1,674) (2,987)  
Prepaid expenses and other current assets         863 (3,603)  
Accounts payable         (2,937) 3,720  
Accrued liabilities         (3,774) 7,031  
Other operating assets and liabilities, net         3,892 (83)  
Net cash used in operating activities         (600) (14,494)  
Cash flows from investing activities:              
Other investing activities         (295) 38  
Net cash (used in) provided by investing activities         (295) 38  
Cash flows from financing activities:              
Proceeds from issuance of stock and warrants         86 13,012  
Net proceeds received from, short-term line of credit         18 6,590  
Payment made to fixed payment arrangement         (2,204) (4,117)  
Payment of stock issuance costs         (160) (1,045)  
Payments made to borrowings         (70) (73)  
Payment for debt issuance costs         0 (92)  
Net cash (used in) provided by financing activities         (2,330) 14,275  
Net change in cash and cash equivalents         (3,225) (181)  
Cash and cash equivalents at beginning of period   $ 22,985   $ 19,360 22,985 19,360 $ 19,360
Cash and cash equivalents at end of period $ 19,760   $ 19,179   19,760 19,179 $ 22,985
Supplemental disclosure of cash flow information:              
Cash paid for interest         3,164 2,861  
Cash paid for income taxes         562 0  
Non-cash investing and financing activities:              
Other noncash investing and financing activities         $ 718 $ 0